This Solicitation opportunity from Department Of Defense was posted on December 18, 2024. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Budesonide Inhalation Suspension

Closed

Solicitation_SPE2D224R0005Federal

Submission Closed05/02/2024, 07:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

Sterile X-Ray Detectable Packing Gauze SupplierThis subcontract involves the supply of 640 units of sterile, medical-grade packing gauze for prime contractors supporting Department of Defense medical supply contracts. The required product is a 1-ply, soft, white Z-fold gauze measuring 3 inches by 5 yards, featuring an embedded X-ray detectable line. To ensure clinical safety and longevity, the gauze must be sterilized to medical standards to maintain a shelf life of 60 months. The contract is managed under the Medical Supply Chain MD Surg FSF and requires strict adherence to the Berry Amendment and the Buy American Act for NSN 6510-01-695-5824. Performance for this requirement is centered in San Diego, California. Interested parties must note the response deadline of November 3, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Tolnaftate Powder (USP 1%)This subcontract involves the supply of Tolnaftate Powder, USP 1%, to prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The requirement specifies the delivery of two bottles of pharmaceutical product, with each unit consisting of a 45 GM sealed container. All supplies must strictly adhere to United States Pharmacopeia standards and utilize commercial packaging and packing methods to ensure the integrity of the contents. The opportunity is categorized under NAICS code 325412 and is associated with a performance location in FPO 96678. Interested parties must note the response deadline of November 3, 2026, following the posting date of October 28, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Lidocaine Hydrochloride and Dextrose Injection ManufacturerThis subcontract involves the manufacture and supply of sterile, nonpyrogenic Lidocaine Hydrochloride and Dextrose Injection to support prime contractors fulfilling Department of Defense supply contracts through the Medical Supply Chain Pharm FSA. The production process requires compounding 2g of Lidocaine Hydrochloride USP and 5g of Hydrous Dextrose USP with Water for Injection USP to achieve a 500 ML bag fill volume. All manufacturing must occur in sterile compounding environments using containers that are latex-free, DEHP-free, and PVC-free to ensure full compliance with USP standards and FDA requirements. The performance of this contract is based in Williamsburg, Virginia, under NAICS code 325412. The scope of work concludes with the delivery of finished sterile injection bags. Interested parties should note the response deadline of November 3, 2026, for this specific procurement opportunity.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Electrical Insulation Tape (NSN 5970010124280)This subcontract involves the supply of electrical insulation tape to prime contractors supporting Defense Logistics Agency Weapons Support aviation supply contracts. The requirement is for two rolls of tape in 36-yard units that strictly adhere to NSN 5970010124280 specifications. The contractor must ensure rigorous quality control and logistics compliance, performing sampling according to MIL-STD-1916 or ASQ H1331 Table 1. Additionally, all materials must be packaged and marked in accordance with MIL-STD-2073-1E, RP001, and MIL-STD-129 standards. This opportunity falls under NAICS code 325412 and is managed by the Department of Defense.

Defense Logistics Agency

POSTED

DEADLINE

Salicylic Acid Plaster SupplierThis subcontract involves the manufacture and supply of Salicylic Acid Plasters for prime contractors serving the Department of Defense Medical Supply Chain. The required plasters must measure 5.08 cm by 7.62 cm, feature a flannel back, and consist of a composition of 40 percent salicylic acid and 60 percent base. Each order must be packaged in units of 25 and maintain a minimum shelf life of 24 months. The supplier is responsible for delivering items under NSN 6510011202643 while ensuring full compliance with MIL-STD-129 and DFARS 252.225-7001 standards. Performance for this contract is designated for FPO 09592-4700, with the procurement falling under NAICS code 325412.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Salicylic Acid Gel Supplier

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Isopropyl Alcohol (99% Isopropanol) SupplierThis subcontract involves the sourcing and manufacture of medical-grade 99 percent Isopropyl Alcohol to support prime contractors for the Department of Defense Medical Supply Chain Pharm FSA. The supplier is responsible for ensuring that all isopropanol meets USP Over-the-Counter standards and is produced using USP grade chemical materials within compliant bottling facilities. Key deliverables include the provision of the alcohol in bottles along with Safety Data Sheets for approval by the contracting officer. The performance of this contract is centered in FPO 96672, with a response deadline set for November 3, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Bacitracin Zinc and Polymyxin B Sulfate OintmentThis subcontract involves the supply of Bacitracin Zinc and Polymyxin B Sulfate Ointment to prime contractors supporting DLA Troop Support medical supply contracts. The product must be provided in 1/32 oz unit-dose foil packets, with each package containing 144 units. The contract requires strict adherence to USP standards and specifies a non-extendable shelf life of 36 months under Type I, Code Q. Managed by the Department of Defense Medical Supply Chain Pharm FSA, the agreement covers the delivery of 1,000 packages. Performance for this contract is based in Williamsburg, Virginia, under NAICS code 325412. The solicitation was posted on October 28, 2026, with a response deadline of November 3, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of Blue Pressure Sensitive Adhesive Tape (NSN 7510-01-679-4381)This subcontract involves the supply of blue pressure-sensitive adhesive tape for prime contractors supporting Department of Defense supply contracts. The required product is 1 inch wide by 72 yards long, specifically 3M Company part numbers 7000049597 or 8901. All deliverables must strictly adhere to MIL-STD-129 for marking, MIL-STD-2073-1E for packaging, and DLA RP001 for palletization standards. The contract mandates full compliance with the Buy American Act and the Berry Amendment. Physical rolls of tape are to be delivered to the DLA destination in Cherry Point, zip code 28533-8051. The opportunity is categorized under NAICS code 325412 and is managed by the Construction and Equipment T & IFO EQ agency.

CONSTRUCTION & EQUIPMENT T & IFO EQ

POSTED

DEADLINE

LIDOCAINE HYDROCHLORID

Solicitation # SPE2DP-27-T-0191

Solicitation SPE2DP-27-T-0191 is a Request for Quotations issued by the Defense Logistics Agency for the procurement of Lidocaine Hydrochloride and Dextrose Injection, USP. The required product is a sterile, nonpyrogenic solution for intravenous use, provided in single-dose containers that are latex-free, DEHP-free, and PVC-free. Each 500 ML bag must contain 2 grams of Lidocaine Hydrochloride USP (4 mg/ml) and 5 grams of Hydrous Dextrose USP. The unit of issue is a package of 24 containers, and the item has a non-extendable shelf life of 30 months. Storage is required at room temperature (25°C), with protection from freezing and excessive heat. The contract specifies delivery FOB Destination to the Naval Medical Readiness Logistics Command in Williamsburg, Virginia, with a required delivery timeframe of five days after order. Compliance with Medical Marking Standard No. 1 and packaging standards MIL-STD-2073-1E and MPPWN00001 is mandatory. The procurement is subject to various federal regulations, including the Buy American Act, the Berry Amendment, and FDA regulation. Invoicing must be processed electronically through the Wide Area WorkFlow system. All quotes must be submitted via the DLA Internet Bid Board System, and offerors are encouraged to provide quantity ranges due to volatile demand.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

BACITRACIN ZINC AND PO

Solicitation # SPE2DP-27-T-0194

Solicitation SPE2DP-27-T-0194, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is for the procurement of one package containing 144 unit-dose foil packets of Bacitracin Zinc and Polymyxin B Sulfate Ointment, USP, each packet weighing 0.94 grams. The item, identified by NSN 6505014933826, is a Type I (Code Q) product with a non-extendable shelf life of 36 months and must be stored between 20°C and 25°C. Delivery is required within five days of award, with the destination and acceptance point located at the Naval Med Readiness Logistics Cmd in Williamsburg, Virginia. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and requires packaging and preservation in accordance with MIL-STD-2073-1E and special instructions MPPWN00001. Suppliers must provide Safety Data Sheets and labels compliant with the Hazard Communication Standard 29 CFR 1910.1200. Administrative requirements include electronic invoicing via Wide Area WorkFlow and compliance with various DFARS regulations, including the Buy American Act, safeguarding of covered defense information, and prohibitions on certain telecommunications equipment. Evaluation preferences are provided for HUBZone concerns.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0195

This fixed-price solicitation, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is for the procurement of two bottles of Tolnaftate Powder, USP 1%, 45 GM (NSN 6505014807897). The contract requires delivery to the USNS Salvor T ARS 52 at FPO AP 96678 within 20 days after order, with an original required delivery date of October 29, 2026. The item is classified as a Type I (Code Q) item with a non-extendable shelf life of 36 months. Inspection and acceptance will occur at the destination. Packaging must be commercial and compliant with the DLA Master List of Technical and Quality Requirements, which takes precedence over ASTM D3951. All units must be in sealed containers and marked according to Medical Marking Standard No. 1 and MIL-STD-129, with palletization following RP001 requirements. The contract incorporates several critical regulatory clauses, including the Buy American Act, Berry Amendment, and DFARS cybersecurity and reporting standards. Invoicing and payment are to be processed electronically through the Wide Area WorkFlow (WAWF) system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 2 hours ago

DEADLINE

in 6 days

AI Contract Overview

This contract pertains to the procurement of Budesonide Inhalation Suspension under solicitation number SPE2D224R0005, issued by the Department of Defense's DLA Troop Support in Philadelphia, PA. The solicitation was posted on December 18, 2024, with a response deadline of May 2, 2024. The contract involves a comprehensive supply arrangement for this pharmaceutical product, which is likely intended to support military or defense-related medical needs. The contract size details are not specified, but the scope includes various packaging options and quantities, as indicated by related documentation such as the updated schedule of supplies for Olanzapine pharmaceuticals, which provides detailed pricing, quantities, and packaging information for different drug forms and dosages. An amendment labeled as Amendment 0007 has been attached to cancel the solicitation, indicating a significant change or termination of the original procurement process. The primary points of contact for this contract are Nancy Fernandez and Catherine Gilbert, both of whom are accessible via email and phone. The contract emphasizes compliance with federal acquisition regulations, as referenced in the supply schedule documentation, and is structured to facilitate procurement planning and fulfillment for the specified pharmaceutical products. The associated online link provides further details and updates related to the solicitation and contract status.